scholarly journals Tolerogenic Dendritic Cells for Therapy of Immune-Mediated Inflammatory Diseases

Author(s):  
Urban vajger ◽  
Borut trukelj
2021 ◽  
Vol 42 (1) ◽  
pp. 59-75
Author(s):  
Octavio Morante-Palacios ◽  
Federico Fondelli ◽  
Esteban Ballestar ◽  
Eva M. Martínez-Cáceres

2021 ◽  
Vol 22 (15) ◽  
pp. 8274
Author(s):  
Shaghayegh Baradaran Ghavami ◽  
Hamid Asadzadeh Aghdaei ◽  
Dario Sorrentino ◽  
Shabnam Shahrokh ◽  
Maryam Farmani ◽  
...  

Inflammatory bowel diseases (IBDs) are immune-mediated, chronic relapsing diseases with a rising prevalence worldwide in both adult and pediatric populations. Treatment options for immune-mediated diseases, including IBDs, are traditional steroids, immunomodulators, and biologics, none of which are capable of inducing long-lasting remission in all patients. Dendritic cells (DCs) play a fundamental role in inducing tolerance and regulating T cells and their tolerogenic functions. Hence, modulation of intestinal mucosal immunity by DCs could provide a novel, additional tool for the treatment of IBD. Recent evidence indicates that probiotic bacteria might impact immunomodulation both in vitro and in vivo by regulating DCs’ maturation and producing tolerogenic DCs (tolDCs) which, in turn, might dampen inflammation. In this review, we will discuss this evidence and the mechanisms of action of probiotics and their metabolites in inducing tolDCs in IBDs and some conditions associated with them.


2014 ◽  
Vol 21 (16) ◽  
pp. 1898-1909 ◽  
Author(s):  
Enrique Vacas-Cordoba ◽  
Hugo Bastida ◽  
Marjorie Pion ◽  
Aurelien Hameau ◽  
Maksim Ionov ◽  
...  

Author(s):  
A Melgarejo-Ortuño ◽  
RM Romero Jiménez ◽  
E Chamorro De Vega ◽  
A Ais Larisgoitia ◽  
ME Lobato Matilla ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document